June Sherie Almenoff - Jul 1, 2025 Form 4 Insider Report for TENAX THERAPEUTICS, INC. (TENX)

Role
Director
Signature
/s/ S. Halle Vakani, as Attorney-in-Fact
Stock symbol
TENX
Transactions as of
Jul 1, 2025
Transactions value $
$0
Form type
4
Date filed
7/3/2025, 08:14 AM
Previous filing
Jun 18, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Almenoff June Sherie Director 101 GLEN LENNOX DRIVE, SUITE 300, CHAPEL HILL /s/ S. Halle Vakani, as Attorney-in-Fact 2025-07-03 0001492647

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TENX Stock Option (right to buy) Award $0 +80K $0.00 80K Jul 1, 2025 Common Stock 80K $5.75 Direct
holding TENX Stock Option (right to buy) 4 Jul 1, 2025 Common Stock 4 $3,200.00 Direct
holding TENX Stock Option (right to buy) 4 Jul 1, 2025 Common Stock 4 $992.00 Direct
holding TENX Stock Option (right to buy) 100K Jul 1, 2025 Common Stock 100K $5.94 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.